Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
BMC Surgery
Published in: BMC Surgery 1/2023

Open Access 01-12-2023 | Obesity | Research

Bariatric and metabolic surgery in patients with low body mass index: an online survey of 543 bariatric and metabolic surgeons

Authors: Shahab Shahabi Shahmiri, Chetan Parmar, Wah Yang, Panagiotis Lainas, Sjaak Pouwels, Amir Hossein DavarpanahJazi, Sonja Chiappetta, Yosuke Seki, Islam Omar, Ramon Vilallonga, Radwan Kassir, Syed Imran Abbas, Ahmad Bashir, Rishi Singhal, Lilian Kow, Mohammad Kermansaravi

Published in: BMC Surgery | Issue 1/2023

Login to get access

Abstract

Background

Metabolic and bariatric surgery (MBS) in patients with low body mass index patients is a topic of debate. This study aimed to address all aspects of controversies in these patients by using a worldwide survey.

Methods

An online 35-item questionnaire survey based on existing controversies surrounding MBS in class 1 obesity was created by 17 bariatric surgeons from 10 different countries. Responses were collected and analysed by authors.

Results

A total of 543 bariatric surgeons from 65 countries participated in this survey. 52.29% of participants agreed with the statement that MBS should be offered to class-1 obese patients without any obesity related comorbidities. Most of the respondents (68.43%) believed that MBS surgery should not be offered to patients under the age of 18 with class I obesity. 81.01% of respondents agreed with the statement that surgical interventions should be considered after failure of non-surgical treatments.

Conclusion

This survey demonstrated worldwide variations in metabolic/bariatric surgery in patients with class 1 obesity. Precise analysis of these results is useful for identifying different aspects for future research and consensus building.
Literature
1.
Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants. Lancet. 2016;387(10026):1377-96.
2.
Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Aminian A, Brethauer SA, et al. Bariatric Surgery versus Intensive Medical Therapy for Diabetes - 5-Year Outcomes. N Engl J Med. 2017;376(7):641–51.PubMedPubMedCentral
3.
Gastrointestinal surgery for severe obesity. National Institutes of Health Consensus Development Conference Statement. Am J Clin Nutr. 1992;55(2 Suppl):615s–s619.
4.
Stegenga H, Haines A, Jones K, Wilding J. Identification, assessment, and management of overweight and obesity: summary of updated NICE guidance. Bmj. 2014;349.
5.
Huang Z-P, Guo Y, Liu C-Q, Qi L, Zou D-J, Zhou W-P. The effect of metabolic surgery on nonobese patients (BMI< 30 kg/m2) with type 2 diabetes: a systematic review. Surgery for Obesity and Related Diseases. 2018;14(6):810–20.PubMed
6.
Reis CE, Alvarez-Leite JI, Bressan J, Alfenas RC. Role of bariatric-metabolic surgery in the treatment of obese type 2 diabetes with body mass index< 35 kg/m2: a literature review. Diabetes Technol Ther. 2012;14(4):365–72.PubMed
7.
Parmar CD, Zakeri R, Mahawar K. A systematic review of one anastomosis/mini gastric bypass as a metabolic operation for patients with body mass index≤ 35 kg/m 2. Obes Surg. 2020;30(2):725–35.PubMed
8.
le Roux C, Aroda V, Hemmingsson J, Cancino AP, Christensen R, Pi-Sunyer X. Comparison of Efficacy and Safety of Liraglutide 3.0 mg in Individuals with BMI above and below 35 kg/m2: A Post-hoc Analysis. Obesity facts. 2017;10(6):531–44.
9.
Yoon JY, Arau RT. The efficacy and safety of endoscopic sleeve gastroplasty as an alternative to laparoscopic sleeve gastrectomy. Clinical Endoscopy. 2021;54(1):17.PubMedPubMedCentral
10.
Eisenberg D, Shikora SA, Aarts E, Aminian A, Angrisani L, Cohen RV, et al. 2022 American Society for Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO): Indications for Metabolic and Bariatric Surgery. Surg Obes Relat Dis. 2022;18(12):1345–56.PubMed
11.
Feng X, Andalib A, Brethauer SA, Schauer PR, Aminian A. How safe is bariatric surgery in patients with class I obesity (body mass index 30–35 kg/m(2))? Surg Obes Relat Dis. 2019;15(2):253–60.PubMed
12.
Busetto L, Dixon J, De Luca M, Shikora S, Pories W, Angrisani L. Bariatric surgery in class I obesity : a Position Statement from the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO). Obes Surg. 2014;24(4):487–519.PubMed
13.
An S, Park HY, Oh SH, Heo Y, Park S, Jeon SM, et al. Cost-effectiveness of Bariatric Surgery for People with Morbid Obesity in South Korea. Obes Surg. 2020;30(1):256–66.PubMed
14.
Gallagher D, Heymsfield SB, Heo M, Jebb SA, Murgatroyd PR, Sakamoto Y. Healthy percentage body fat ranges: an approach for developing guidelines based on body mass index. Am J Clin Nutr. 2000;72(3):694–701.PubMed
15.
Worldwide trends in body-mass index. underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults. Lancet. 2017;390(10113):2627–42.
16.
Rubino F, Nathan DM, Eckel RH, Schauer PR, Alberti KG, Zimmet PZ, et al. Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations. Surg Obes Relat Dis. 2016;12(6):1144–62.PubMed
17.
Noun R, Slim R, Nasr M, Chakhtoura G, Gharios J, Antoun NA, et al. Results of Laparoscopic Sleeve Gastrectomy in 541 Consecutive Patients with Low Baseline Body Mass Index (30–35 kg/m(2)). Obes Surg. 2016;26(12):2824–8.PubMed
18.
O’Brien PE, Brennan L, Laurie C, Brown W. Intensive medical weight loss or laparoscopic adjustable gastric banding in the treatment of mild to moderate obesity: long-term follow-up of a prospective randomised trial. Obes Surg. 2013;23(9):1345–53.PubMed
19.
Hong JS, Kim WW, Han SM. Five-year results of laparoscopic sleeve gastrectomy in Korean patients with lower body mass index (30–35 kg/m2). Obes Surg. 2015;25(5):824–9.PubMed
20.
Ke Z, Li F, Gao Y, Tan D, Sun F, Zhou X, et al. The Use of Visceral Adiposity Index to Predict Diabetes Remission in Low BMI Chinese Patients After Bariatric Surgery. Obes Surg. 2021;31(2):805–12.PubMed
21.
Vallois A, Menahem B, Alves A. Is Laparoscopic Bariatric Surgery Safe and Effective in Patients over 60 Years of Age?" an Updated Systematic Review and Meta-Analysis. Obes Surg. 2020;30(12):5059–70.PubMed
22.
Shoar S, Mahmoudzadeh H, Naderan M, Bagheri-Hariri S, Wong C, Parizi AS, et al. Long-Term Outcome of Bariatric Surgery in Morbidly Obese Adolescents: a Systematic Review and Meta-Analysis of 950 Patients with a Minimum of 3 years Follow-Up. Obes Surg. 2017;27(12):3110–7.PubMed
23.
Beamish AJ, Harper ER, Järvholm K, Janson A, Olbers T. Long-term outcomes following adolescent metabolic and bariatric surgery. The Journal of clinical endocrinology and metabolism. 2023.
24.
Olbers T, Beamish AJ, Gronowitz E, Flodmark CE, Dahlgren J, Bruze G, et al. Laparoscopic Roux-en-Y gastric bypass in adolescents with severe obesity (AMOS): a prospective, 5-year, Swedish nationwide study. Lancet Diabetes Endocrinol. 2017;5(3):174–83.PubMedPubMedCentral
25.
Hoerger TJ. Economics and Policy in Bariatric Surgery. Curr Diab Rep. 2019;19(6):29.PubMed
26.
De Luca M, Angrisani L, Himpens J, Busetto L, Scopinaro N, Weiner R, et al. Indications for Surgery for Obesity and Weight-Related Diseases: Position Statements from the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO). Obes Surg. 2016;26(8):1659–96.PubMedPubMedCentral
27.
Mechanick JI, Apovian C, Brethauer S, Timothy Garvey W, Joffe AM, Kim J, et al. Clinical Practice Guidelines for the Perioperative Nutrition, Metabolic, and Nonsurgical Support of Patients Undergoing Bariatric Procedures - 2019 Update: Cosponsored by American Association of Clinical Endocrinologists/American College of Endocrinology, The Obesity Society, American Society for Metabolic and Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists. Obesity (Silver Spring, Md). 2020;28(4):O1–o58.PubMed
28.
Parrott J, Frank L, Rabena R, Craggs-Dino L, Isom KA, Greiman L. American Society for Metabolic and Bariatric Surgery Integrated Health Nutritional Guidelines for the Surgical Weight Loss Patient 2016 Update: Micronutrients. Surg Obes Relat Dis. 2017;13(5):727–41.PubMed
29.
Friedrichsen M, Breitschaft A, Tadayon S, Wizert A, Skovgaard D. The effect of semaglutide 2.4 mg once weekly on energy intake, appetite, control of eating, and gastric emptying in adults with obesity. Diabetes Obes Metab. 2021;23(3):754–62.PubMedPubMedCentral
30.
Newsome PN, Buchholtz K, Cusi K, Linder M, Okanoue T, Ratziu V, et al. A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis. N Engl J Med. 2021;384(12):1113–24.PubMed
31.
Li J, He K, Ge J, Li C, Jing Z. Efficacy and safety of the glucagon-like peptide-1 receptor agonist oral semaglutide in patients with type 2 diabetes mellitus: A systematic review and meta-analysis. Diabetes Res Clin Pract. 2021;172: 108656.PubMed
32.
le Roux CW, Zhang S, Aronne LJ, Kushner RF, Chao AM, Machineni S, et al. Tirzepatide for the treatment of obesity: Rationale and design of the SURMOUNT clinical development program. Obesity (Silver Spring, Md). 2023;31(1):96–110.PubMed
33.
Pedrosa MR, Franco DR, Gieremek HW, Vidal CM, Bronzeri F, de Cassia RA, et al. GLP-1 Agonist to Treat Obesity and Prevent Cardiovascular Disease: What Have We Achieved so Far? Curr Atheroscler Rep. 2022;24(11):867–84.PubMed
34.
Ponce J, Woodman G, Swain J, Wilson E, English W, Ikramuddin S, et al. The REDUCE pivotal trial: a prospective, randomized controlled pivotal trial of a dual intragastric balloon for the treatment of obesity. Surg Obes Relat Dis. 2015;11(4):874–81.PubMed
35.
Kotzampassi K, Grosomanidis V, Papakostas P, Penna S, Eleftheriadis E. 500 intragastric balloons: what happens 5 years thereafter? Obes Surg. 2012;22(6):896–903.PubMed
36.
Chan DL, Cruz JR, Mui WL, Wong SKH, Ng EKW. Outcomes with Intra-gastric Balloon Therapy in BMI < 35 Non-morbid Obesity: 10-Year Follow-Up Study of an RCT. Obes Surg. 2021;31(2):781–6.PubMed
37.
Singh S, de Moura DTH, Khan A, Bilal M, Chowdhry M, Ryan MB, et al. Intragastric Balloon Versus Endoscopic Sleeve Gastroplasty for the Treatment of Obesity: a Systematic Review and Meta-analysis. Obes Surg. 2020;30(8):3010–29.PubMedPubMedCentral
38.
Cheskin LJ, Hill C, Adam A, Fayad L, Dunlap M, Badurdeen D, et al. Endoscopic sleeve gastroplasty versus high-intensity diet and lifestyle therapy: a case-matched study. Gastrointest Endosc. 2020;91(2):342–9.e1.PubMed
39.
Fiorillo C, Quero G, Vix M, Guerriero L, Pizzicannella M, Lapergola A, et al. 6-Month Gastrointestinal Quality of Life (QoL) Results after Endoscopic Sleeve Gastroplasty and Laparoscopic Sleeve Gastrectomy: A Propensity Score Analysis. Obes Surg. 2020;30(5):1944–51.PubMed
40.
Angrisani L, Santonicola A, Iovino P, Vitiello A, Higa K, Himpens J, et al. IFSO Worldwide Survey 2016: Primary, Endoluminal, and Revisional Procedures. Obes Surg. 2018;28(12):3783–94.PubMed
41.
Keating CL, Dixon JB, Moodie ML, Peeters A, Playfair J, O’Brien PE. Cost-efficacy of surgically induced weight loss for the management of type 2 diabetes: a randomized controlled trial. Diabetes Care. 2009;32(4):580–4.PubMedPubMedCentral
42.
Picot J, Jones J, Colquitt JL, Loveman E, Clegg AJ. Weight loss surgery for mild to moderate obesity: a systematic review and economic evaluation. Obes Surg. 2012;22(9):1496–506.PubMed
43.
Kermansaravi M, Shahmiri SS, Davarpanah Jazi AH, Valizadeh R, Weiner RA, Chiappetta S. Reversal to normal anatomy after one-anastomosis/mini gastric bypass, indications and results: a systematic review and meta-analysis. Surg Obes Relat Dis. 2021;17(8):1489–96.PubMed
44.
van Rutte PW, Smulders JF, de Zoete JP, Nienhuijs SW. Outcome of sleeve gastrectomy as a primary bariatric procedure. Br J Surg. 2014;101(6):661–8.PubMed
45.
Castagneto Gissey L, Casella Mariolo JR, Genco A, Troisi A, Basso N, Casella G. 10-year follow-up after laparoscopic sleeve gastrectomy: Outcomes in a monocentric series. Surg Obes Relat Dis. 2018;14(10):1480–7.PubMed
46.
Goldberg I, Yang J, Nie L, Bates AT, Docimo S Jr, Pryor AD, et al. Safety of bariatric surgery in patients older than 65 years. Surg Obes Relat Dis. 2019;15(8):1380–7.PubMed
47.
Lainas P, De Filippo G, Di Giuro G, Mikhael R, Bougneres P, Dagher I. Laparoscopic Sleeve Gastrectomy for Adolescents Under 18 Years Old with Severe Obesity. Obes Surg. 2020;30(1):267–73.PubMed
48.
Howard R, Chao GF, Yang J, Thumma J, Chhabra K, Arterburn DE, et al. Comparative Safety of Sleeve Gastrectomy and Gastric Bypass Up to 5 Years After Surgery in Patients With Severe Obesity. JAMA Surg. 2021;156(12):1160–9.PubMedPubMedCentral
49.
Zerrweck C, Herrera A, Sepúlveda EM, Rodríguez FM, Guilbert L. Long versus short biliopancreatic limb in Roux-en-Y gastric bypass: short-term results of a randomized clinical trial. Surg Obes Relat Dis. 2021;17(8):1425–30.PubMed
50.
Zorrilla-Nunez LF, Campbell A, Giambartolomei G, Lo Menzo E, Szomstein S, Rosenthal RJ. The importance of the biliopancreatic limb length in gastric bypass: A systematic review. Surg Obes Relat Dis. 2019;15(1):43–9.PubMed
51.
Darabi S, Pazouki A, Hosseini-Baharanchi FS, Kabir A, Kermansaravi M. The role of alimentary and biliopancreatic limb length in outcomes of Roux-en-Y gastric bypass. Wideochir Inne Tech Maloinwazyjne. 2020;15(2):290–7.PubMed
52.
Ma P, Ghiassi S, Lloyd A, Haddad A, Boone K, DeMaria E, et al. Reversal of Roux en Y gastric bypass: largest single institution experience. Surg Obes Relat Dis. 2019;15(8):1311–6.PubMed
53.
Lainas P, Derienne J, Dammaro C, Schoucair N, Devaquet N, Dagher I. Single-port Laparoscopic Surgery for the Treatment of Severe Obesity: Review and Perspectives. Obes Surg. 2020;30(7):2781–90.PubMed
54.
Lainas P, Derienne J, Zervaki S, Del Basso C, Malerba V, Devaquet N, et al. Left Hypochondrium or Transumbilical Single-Incision Laparoscopic Sleeve Gastrectomy for the Treatment of Severe Obesity: Surgical Technique and Results of a Tertiary Referral Bariatric Center. Obes Surg. 2021;31(11):5063–70.PubMed
55.
O’Kane M, Parretti HM, Pinkney J, Welbourn R, Hughes CA, Mok J, et al. British Obesity and Metabolic Surgery Society Guidelines on perioperative and postoperative biochemical monitoring and micronutrient replacement for patients undergoing bariatric surgery-2020 update. Obes Rev. 2020;21(11): e13087.PubMedPubMedCentral
56.
Hosseini-Esfahani F, Khalaj A, Valizadeh M, Azizi F, Barzin M, Mirmiran P. Nutrient Intake and Deficiency of Patients 1 Year After Bariatric Surgery: Tehran Obesity Treatment Study (TOTS). J Gastrointest Surg. 2021;25(4):911–8.PubMed
57.
Zhang W, Fan M, Wang C, Mahawar K, Parmar C, Chen W, et al. Hair Loss After Metabolic and Bariatric Surgery: a Systematic Review and Meta-analysis. Obes Surg. 2021;31(6):2649–59.PubMedPubMedCentral
58.
Zhang W, Fan M, Wang C, Mahawar K, Parmar C, Chen W, et al. Importance of Maintaining Zinc and Copper Supplement Dosage Ratio After Metabolic and Bariatric Surgery. Obes Surg. 2021;31(7):3339–40.PubMed
59.
Brethauer SA, Kim J, El Chaar M, Papasavas P, Eisenberg D, Rogers A, et al. Standardized outcomes reporting in metabolic and bariatric surgery. Obes Surg. 2015;25(4):587–606.PubMed
60.
Yang W, Wang C. Metabolic Surgery Needs Stronger Endorsement in Asian T2DM Patients with Low BMI. Obes Surg. 2022;32(1):212–3.PubMed
Metadata
Title
Bariatric and metabolic surgery in patients with low body mass index: an online survey of 543 bariatric and metabolic surgeons
Authors
Shahab Shahabi Shahmiri
Chetan Parmar
Wah Yang
Panagiotis Lainas
Sjaak Pouwels
Amir Hossein DavarpanahJazi
Sonja Chiappetta
Yosuke Seki
Islam Omar
Ramon Vilallonga
Radwan Kassir
Syed Imran Abbas
Ahmad Bashir
Rishi Singhal
Lilian Kow
Mohammad Kermansaravi
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Surgery / Issue 1/2023
Electronic ISSN: 1471-2482
DOI
https://doi.org/10.1186/s12893-023-02175-4

Other articles of this Issue 1/2023

BMC Surgery 1/2023 Go to the issue

Research

Comparison of the efficacy of ETS with different segments for palmar, axillary and plantar hyperhidrosis

Research

Application of 3D-printed pulmonary segment specimens in experimental teaching of sectional anatomy

Research article

Laparoscopic hiatal hernia repair for treating patients with massive hiatal hernia and iron-deficiency anaemia

Correction

Correction: Factors related to T1 slope: spinopelvic balance and thoracic compensation

Research

Revitalize splenic functions. Following a splenectomy for trauma, a small amount of splenic autotransplantation was performed

Research

Assessment of mathematical model for elliptical excision: solving the doubt about vertex angle and predicting postoperative wound length